Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial
Author:
Funder
UCB Pharma
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology
Reference30 articles.
1. Conversion to brivaracetam monotherapy for the treatment of patients with focal seizures: two double-blind, randomized, multicenter, historical control, phase III studies;Arnold;Epilepsy Res.,2018
2. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy;Ben-Menachem;Epilepsy Res.,2003
3. Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies;Ben-Menachem;Neurology,2016
4. Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis;Brandt;Epilepsy Behav.,2020
5. Brivaracetam add-on therapy for drug-resistant epilepsy;Bresnahan;Cochrane Database Syst. Rev.,2019
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single intravenous and oral dose pharmacokinetics of the antiseizure medication brivaracetam in healthy cats;Journal of Veterinary Pharmacology and Therapeutics;2024-07-17
2. Efficacy and Tolerability of Brivaracetam in Chinese Population: Focus on Switch From Levetiracetam;American Journal of Therapeutics;2022-05-23
3. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht–Lundborg disease: An open-label, long-term follow-up trial;Epilepsy Research;2021-02
4. Treatment of Seizures in Older Patients with Dementia;Drugs & Aging;2020-12-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3